Takeda Pharmaceutical (TAK) Net Margin (2017 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Net Margin of 9.28% for Q2 2026, down 195.0% year-over-year from 9.77% in Q2 2025, and down 8.86% quarter-over-quarter from 10.18% in Q1 2026.
Takeda Pharmaceutical (TAK) Net Margin (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's Net Margin history runs 10 years deep, the most recent figure standing at 9.28% for Q2 2026.
- In Q2 2026, Net Margin fell 195.0% year-over-year to 9.28%; the TTM figure through Jun 2026 stood at 1.24% (down 399.0% YoY), while the FY2026 annual figure was 3.38%, down 574.0% from the prior year.
- Net Margin for Q2 2026 stood at 9.28%, down from 10.18% in the prior quarter.
- The five-year high for Net Margin was 11.23% in Q2 2025, with the low at 33.67% in Q4 2025.
- The 5-year median for Net Margin is 8.16% (2023), against an average of 4.57%.
- The sharpest annual moves came in 2022 and 2023: Net Margin tumbled 2676 bps in 2022, then soared 1109 bps in 2023.
- Takeda Pharmaceutical's Net Margin stood at 10.86% in 2022, then plunged by 73 bps to 2.96% in 2023, then slumped by 431 bps to 9.8% in 2024, then plunged by 244 bps to 33.67% in 2025, then soared by 128 bps to 9.28% in 2026.
- Business Quant data shows TAK's Net Margin at 9.28% in Q2 2026, 10.18% in Q1 2026, and 33.67% in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | 0.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.28% |
| Mar 31, 2026 | 10.18% |
| Dec 31, 2025 | -33.67% |
| Sep 30, 2025 | 6.12% |
| Jun 30, 2025 | 11.23% |
| Mar 31, 2025 | 10.28% |
| Dec 31, 2024 | -9.80% |
| Sep 30, 2024 | 5.98% |
| Jun 30, 2024 | 7.88% |
| Mar 31, 2024 | 7.88% |
| Dec 31, 2023 | 2.96% |
| Sep 30, 2023 | 8.90% |
| Jun 30, 2023 | 8.44% |
| Mar 31, 2023 | 9.92% |
| Dec 31, 2022 | 10.86% |
| Sep 30, 2022 | 6.16% |
| Jun 30, 2022 | 10.80% |
| Mar 31, 2022 | -1.17% |
| Dec 31, 2021 | 6.41% |
| Sep 30, 2021 | 5.44% |